We improve people's quality of life through the study of vaccines
We improve people's quality of life
through the study of vaccines
Our purpose
We study the vaccines and the impact they have on society, the infectious diseases that can be prevented by vaccination.
The Vaccine Research Area also has a educational and informative vocation which translates into the organization of courses, conferences and webinars focused on updating health professionals on issues related to vaccines, informing and training the general population.
+
0
Clinical Trials
+
0
Subjects Recruited
0
Publications
0
Competitive
Projects
Projects
What do we do?
The activities that we develop are grouped in:
- Clinical Trials: We participate in clinical trials on vaccine safety and efficacy.
- Studies with Real World Data:They allow us to carry out high-quality population studies.
- Prospective Studies:: We participate and coordinate
hospital surveillance networks for the investigation of infectious diseases. - Ethical And Gender Aspects: We facilitate the understanding of informed consent in clinical research, promoting its participation.
Competitive
Projects
Projects
Would you like to make a donation?
If you want to help us in any of our projects, you can fill out the form, write to us at vacunas_fisabio@gva.es, or call us at 900 102 963. Thanks!
We will also inform you of the AEAT deductions you would be entitled to.
Latest News
Un estudio del Área de Vacunas de Fisabio analiza el impacto del SARS-CoV-2 en mujeres embarazadas
El Área de Vacunas participa en un proyecto financiado por la Organización Mundial de la Salud (OMS) para estudiar el impacto de la COVID-19 en mujeres embarazadas.
Herpes Zóster, VPH, Rotavirus y Meningococo en los más vulnerables
El jueves se estrenaba "Los vulnerables", el último capítulo la Trilogía de las Vacunas para hablar de HZ, VPH, Rotavirus y Meningococo en los grupos de riesgo.
Prevención Integral de Neumonías (Bacterias y Virus)
Ayer se estrenaba el capítulo dos de la Trilogía de Vacunas. Porque no todo es COVID-19, hablamos de viejos conocidos como el virus influenza, neumococo y VRS.
